Harvard Bioscience Schedules Second Quarter 2024 Earnings Conference Call for August 8, 2024 at 10:00 AM ET
Harvard Bioscience (Nasdaq: HBIO) has announced its schedule for the second quarter 2024 earnings conference call, set for August 8, 2024, at 10:00 AM ET. The company will release its financial results for the quarter ended June 30, 2024, before the market opens on the same day. Interested participants can register for the call to ask questions, while an audio-only webcast option is also available. Financial information, including the earnings release and a related slide presentation, will be accessible on the Investor Relations section of Harvard Bioscience's website.
Harvard Bioscience (Nasdaq: HBIO) ha annunciato il programma per la conferenza telefonica sui risultati finanziari del secondo trimestre 2024, prevista per 8 agosto 2024, alle 10:00 AM ET. L'azienda pubblicherà i suoi risultati finanziari per il trimestre conclusosi il 30 giugno 2024, prima dell'apertura del mercato nella stessa giornata. I partecipanti interessati possono registrarsi per la chiamata per porre domande, mentre sarà anche disponibile un'opzione di webcast audio-only. Le informazioni finanziarie, compresi il comunicato sugli utili e una presentazione visiva correlata, saranno accessibili nella sezione Relazioni con gli Investitori del sito web di Harvard Bioscience.
Harvard Bioscience (Nasdaq: HBIO) ha anunciado su programación para la conferencia telefónica de resultados del segundo trimestre de 2024, programada para el 8 de agosto de 2024, a las 10:00 AM ET. La compañía publicará sus resultados financieros para el trimestre que finalizó el 30 de junio de 2024, antes de la apertura del mercado ese mismo día. Los participantes interesados pueden registrarse para la llamada y hacer preguntas, y también hay una opción de webcast solo de audio disponible. La información financiera, incluyendo el comunicado de ganancias y una presentación de diapositivas relacionada, estará disponible en la sección de Relaciones con Inversores del sitio web de Harvard Bioscience.
하버드 바이오사이언스(Nasdaq: HBIO)는 2024년 2분기 실적 발표 콘퍼런스 콜 일정을 발표했습니다. 일시는 2024년 8월 8일 오전 10:00 ET입니다. 회사는 2024년 6월 30일에 종료된 분기 실적을 같은 날 시장이 열리기 전에 공개할 예정입니다. 관심 있는 참여자는 질문을 하려면 전화를 등록할 수 있으며, 오디오 전용 웹 캐스트 옵션도 제공됩니다. 재무 정보는 실적 발표 및 관련 슬라이드 프레젠테이션을 포함해 하버드 바이오사이언스 웹사이트의 투자자 관계 섹션에서 확인할 수 있습니다.
Harvard Bioscience (Nasdaq: HBIO) a annoncé son programme pour la conférence téléphonique sur les résultats du deuxième trimestre 2024, qui aura lieu le 8 août 2024, à 10h00 ET. L’entreprise publiera ses résultats financiers pour le trimestre terminé le 30 juin 2024, avant l’ouverture du marché le même jour. Les participants intéressés peuvent s'inscrire à l'appel pour poser des questions, tandis qu'une option de webdiffusion audio uniquement sera également disponible. Les informations financières, y compris le communiqué de presse sur les bénéfices et une présentation liée, seront accessibles dans la section Relations Investisseurs du site web de Harvard Bioscience.
Harvard Bioscience (Nasdaq: HBIO) hat den Zeitplan für die Ergebniskonferenz des zweiten Quartals 2024 bekannt gegeben, die für 8. August 2024, um 10:00 Uhr ET angesetzt ist. Das Unternehmen wird seine Finanzergebnisse für das am 30. Juni 2024 endende Quartal noch vor der Markteröffnung am selben Tag veröffentlichen. Interessierte Teilnehmer können sich zur Konferenz anmelden, um Fragen zu stellen, außerdem gibt es eine Audio-Only-Webcast-Option. Finanzinformationen, einschließlich des Gewinnberichts und einer zugehörigen Präsentation, werden im Bereich Investor Relations der Harvard Bioscience-Website verfügbar sein.
- None.
- None.
HOLLISTON, Mass., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended June 30, 2024 before the market opens on August 8, 2024, and will hold a conference call to discuss the results at 10:00 a.m. Eastern Time.
Participants who would like to join the call and ask a question must register here. Once registered, you will receive the dial-in numbers and a unique PIN number.
Participants who would like to join the audio-only webcast should go to our events and presentations on the investor website here.
Financial information presented on the call, including the earnings release and a related slide presentation, will be available on the Investor Relations section of Harvard Bioscience’s website.
About Harvard Bioscience
Harvard Bioscience, Inc. is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. Our customers range from renowned academic institutions and government laboratories to the world’s leading pharmaceutical, biotechnology and contract research organizations. With operations in the United States, Europe, and China, we sell through a combination of direct and distribution channels to customers around the world.
For more information, please visit our website at www.harvardbioscience.com.
Company Contact:
Jennifer Cote
Chief Financial Officer
(508) 893-3120
Investors Contact:
Three Part Advisors
Sandy Martin / Erol Girgin / William Shelmire
HBIO@threepa.com
(214) 616-2207
FAQ
When is Harvard Bioscience (HBIO) releasing its Q2 2024 earnings?
What time is Harvard Bioscience's (HBIO) Q2 2024 earnings conference call?
How can I participate in Harvard Bioscience's (HBIO) Q2 2024 earnings call?
Where can I find Harvard Bioscience's (HBIO) Q2 2024 financial information and earnings release?
